CoreCap Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

CoreCap Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$697	Buy	+27	New	+$584	﹤0.01%	2735
2026 Q2	–	Sell	-107	Closed	-$2.1K	–	3174
2026 Q1	$2.1K	Hold	107	–	–	﹤0.01%	2404
2025 Q4	$2.86K	Hold	107	–	–	﹤0.01%	2376
2025 Q3	$2.85K	Buy	107 +48	+81%	+$1.24K	﹤0.01%	2308
2025 Q2	$1.36K	Hold	59	–	–	﹤0.01%	2380
2025 Q1	$1.71K	Hold	59	–	–	﹤0.01%	2403
2024 Q4	$2.19K	Hold	59	–	–	﹤0.01%	2199
2024 Q3	$2.86K	Hold	59	–	–	﹤0.01%	2111
2024 Q2	$2.36K	Buy	+59	New	+$2.44K	﹤0.01%	1294

Other funds holding AMPH

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

CoreCap Advisors's AMPH Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 27 shares worth $697. The stake represents ﹤0.01% of the portfolio and ranks #2735 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in AMPH as recently as Q1 2026.

CoreCap Advisors first reported a position in AMPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.86K in Q4 2025. 32 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

CoreCap Advisors held 27 shares of Amphastar Pharmaceuticals worth $697 as of Q3 2026.
Amphastar Pharmaceuticals was a new CoreCap Advisors position in Q3 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2735 holding.
CoreCap Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
CoreCap Advisors's Amphastar Pharmaceuticals position peaked at $2.86K in Q4 2025.
32 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.